Moises Rodriguez-Gonzalez
University of Cádiz
67 Papers
102 Citations
Moises Rodriguez-Gonzalez is an academic researcher from University of Cádiz. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 7, co-authored 53 publications.
Chat about Author
Papers
Cardiovascular impact of COVID-19 with a focus on children: A systematic review.
Moises Rodriguez-Gonzalez,Ana Castellano-Martinez,Helena Maria Cascales-Poyatos,Alvaro Antonio Perez-Reviriego +3 more
TL;DR: Based on the review, children (previously healthy or with pre-existing heart disease) with acute COVID-19 requiring hospital admission should undergo a cardiac workup and close cardiovascular monitoring to identify and treat timely life-threatening cardiac complications.
125
NT-proBNP plasma levels as biomarkers for pulmonary hypertension in healthy infants with respiratory syncytial virus infection.
Moises Rodriguez-Gonzalez,Isabel Benavente-Fernández,Ana Castellano-Martinez,Alfonso M. Lechuga-Sancho,Simón Lubián-López +4 more
TL;DR: The presence of PH in healthy infants with RSVI is associated with worse outcomes and NT-proBNP resulted an accurate biomarker for PH in this setting.
26
New onset severe right ventricular failure associated with COVID-19 in a young infant without previous heart disease.
Moises Rodriguez-Gonzalez,Patricia Rodríguez-Campoy,María Isabel Sánchez-Códez,Irene Gutierrez-Rosa,Ana Castellano-Martinez,Amado Rodríguez-Benítez +5 more
TL;DR: If this presentation is confirmed in future research, the severe cardiovascular impairment in children with COVID-19 could be also attributable to the primary pulmonary infection, not only to a multisystem inflammatory syndrome but also in children without heart disease.
Left Ventricular Dysfunction and Plasmatic NT-proBNP Are Associated with Adverse Evolution in Respiratory Syncytial Virus Bronchiolitis.
Moises Rodriguez-Gonzalez,Alvaro Antonio Perez-Reviriego,Ana Castellano-Martinez,Simón Lubián-López,Isabel Benavente-Fernández +4 more
- 27 Jul 2019
TL;DR: LVMD could be present in healthy infants with RSVB who develop severe disease and N-terminal pro-B-type natriuretic peptide seems to improve traditional clinical markers for outcomes.
20